Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ)
CNY 32.71
(-0.58%)
CNY 32.71
(-0.58%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 3.36 Billion | 3.48 Billion | 3.05 Billion | 2.73 Billion | 4.47 Billion | 4.65 Billion |
| Cost of Revenue | 1.12 Billion | 993.61 Million | 793.27 Million | 847.69 Million | 964.36 Million | 943.67 Million |
| Gross Profit | 2.23 Billion | 2.48 Billion | 2.26 Billion | 1.89 Billion | 3.5 Billion | 3.7 Billion |
| Operating Expenses | 1.65 Billion | 1.85 Billion | 1.68 Billion | 1.52 Billion | 2.61 Billion | 2.01 Billion |
| Selling, General and Administrative Expenses | 1.26 Billion | 1.15 Billion | 1.09 Billion | 947.33 Million | 1.62 Billion | 1.39 Billion |
| Research and Development Expenses | 409.19 Million | 533.74 Million | 357.36 Million | 371.19 Million | 763.49 Million | 407.47 Million |
| Other Expenses | 1.58 Million | 165.36 Million | 233.99 Million | 203.95 Million | 229.04 Million | -13.71 Million |
| Cost and Expenses | 2.7 Billion | 2.84 Billion | 2.48 Billion | 2.37 Billion | 3.58 Billion | 2.95 Billion |
| Operating Income | 655.97 Million | 727.43 Million | 586.19 Million | 348.72 Million | 846.08 Million | 1.71 Billion |
| Interest Expense | 17.87 Million | 12.53 Million | 10.52 Million | 17.56 Million | 16 Million | 6.29 Million |
| Income Tax Expense | 60.93 Million | 79.5 Million | 71.52 Million | 6.6 Million | 169.5 Million | 251.66 Million |
| Earnings before Tax | 641.76 Million | 713.72 Million | 599.84 Million | 56.74 Million | 851.34 Million | 1.7 Billion |
| Net Income | 580.06 Million | 637.09 Million | 533.72 Million | 60.86 Million | 715.2 Million | 1.45 Billion |
| Earnings Per Share Basic | 0.52 | 0.58 | 0.50 | 0.06 | 0.69 | 1.39 |
| Earnings Per Share Diluted | 0.52 | 0.58 | 0.50 | 0.06 | 0.69 | 1.39 |
| Weighted Average Shares Outstanding | 1.11 Billion | 1.09 Billion | 1.06 Billion | 1.02 Billion | 1.04 Billion | 1.04 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.11 Billion | 1.09 Billion | 1.06 Billion | 1.02 Billion | 1.04 Billion | 1.04 Billion |
| Gross Margin | 0.67 | 0.71 | 0.74 | 0.69 | 0.78 | 0.80 |
| EBIT Margin | 0.31 | 0.31 | 0.35 | 0.22 | 0.25 | 0.40 |
| Profit Margin | 0.17 | 0.18 | 0.17 | 0.02 | 0.16 | 0.31 |
| EBITDA | 1.05 Billion | 1.04 Billion | 914.63 Million | 377.1 Million | 1.09 Billion | 1.81 Billion |
| Earnings Before Tax Margin | 0.19 | 0.21 | 0.19 | 0.13 | 0.19 | 0.37 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 958.43 Million | 940.23 Million | 1.09 Billion | 3.32 Billion | 900.3 Million | 772.01 Million |
| Cost of Revenue | 248.48 Million | 295.8 Million | 311.44 Million | 1.12 Billion | 292.09 Million | 261.2 Million |
| Gross Profit | 709.94 Million | 644.43 Million | 779.52 Million | 2.19 Billion | 608.2 Million | 510.81 Million |
| Operating Expenses | 530.29 Million | 513.88 Million | 555.37 Million | 1.64 Billion | 507.03 Million | 353.89 Million |
| Selling, General and Administrative Expenses | 752.97 Million | 425.47 Million | 448.65 Million | - | 358.72 Million | 370.72 Million |
| Research and Development Expenses | 104.2 Million | 85.59 Million | 107.57 Million | - | 144.56 Million | 92.02 Million |
| Other Expenses | -326.89 Million | -2.82 Million | -2.35 Million | 1.58 Million | -3.74 Million | -3.85 Million |
| Cost and Expenses | 778.77 Million | 809.69 Million | 866.82 Million | 2.76 Billion | 799.13 Million | 615.09 Million |
| Operating Income | 179.82 Million | 130.54 Million | 233.08 Million | 552.03 Million | 101.16 Million | 162.1 Million |
| Interest Expense | 4.33 Million | 3.87 Million | 3.95 Million | 17.37 Million | 3.53 Million | 5 Million |
| Income Tax Expense | 9.65 Million | 19.92 Million | 32.62 Million | 60.93 Million | -11.83 Million | 17 Million |
| Earnings before Tax | 177.44 Million | 169.63 Million | 230.73 Million | 657.21 Million | 92.64 Million | 158.4 Million |
| Net Income | 165.62 Million | 143.82 Million | 200.26 Million | 580.06 Million | 100.89 Million | 141.55 Million |
| Earnings Per Share Basic | 0.15 | 0.13 | 0.18 | - | 0.09 | 0.13 |
| Earnings Per Share Diluted | 0.15 | 0.13 | 0.18 | - | 0.09 | 0.13 |
| Weighted Average Shares Outstanding | 1.1 Billion | 1.09 Billion | 1.11 Billion | 1.09 Billion | 1.09 Billion | 1.09 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.1 Billion | 1.09 Billion | 1.11 Billion | 1.09 Billion | 1.09 Billion | 1.09 Billion |
| Gross Margin | 0.74 | 0.69 | 0.71 | 0.66 | 0.68 | 0.66 |
| EBIT Margin | 0.19 | 0.24 | 0.22 | - | 0.22 | 0.21 |
| Profit Margin | 0.17 | 0.15 | 0.18 | 0.17 | 0.11 | 0.18 |
| EBITDA | 181.77 Million | 229.88 Million | 238.33 Million | - | 202.36 Million | 165.78 Million |
| Earnings Before Tax Margin | 0.19 | 0.14 | 0.21 | 0.17 | 0.11 | 0.21 |
JWTXF
MGLU3
ICN
5704
DVAX
NTC